This round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super pro-rata basis.

Endologix announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately. Davis joins with experience in commercial leadership, most recently ...

This funding, supported by institutional investors such as Perceptive Advisors and OrbiMed, is expected to extend the company's financial stability into the first half of 2026. Additionally ...

Revenue increased 28% to $24.7 million compared to $19.4 million for the prior year period. Tissue-based tests accounted for 81% and 76% of total fourth quarter 2024 and 2023 revenue, respectively ...

Peter A. Thompson, a director at Sionna Therapeutics , Inc. (NASDAQ:SION), has made significant stock acquisitions as reported in a recent SEC filing. Thompson purchased 550,000 ...

MDxHealth SA ADR reported better-than-expected earnings for the fourth quarter of 2024, with an earnings per share (EPS) of -$0.14, surpassing the forecasted -$0.19. The company also reported ...

These initiatives are expected to enhance Healios' capabilities in regenerative medicine, supported by collaborations with prominent investors like Athos Capital Limited and OrbiMed Advisors LLC.

Interest expense increased approximately $4.2 million in comparison to the prior year due to the interest expense incurred from the long-term debt of $40.0 million under the OrbiMed Credit Agreement.

Overland Advantage, a business development company with a differentiated direct lending approach that benefits from a strategic relationship between Centerbridge Partners and Wells Fargo, announced ...